ISIS has cancer trial news coming up. I think it's a winner because an analyst cared enough to make up a lie about the trials being bad a couple of weeks ago.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.